awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36226630-6F63694E-E790-4FC5-A0A7-215401847040
Q36226630-6F63694E-E790-4FC5-A0A7-215401847040
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36226630-6F63694E-E790-4FC5-A0A7-215401847040
Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.
P2860
Q36226630-6F63694E-E790-4FC5-A0A7-215401847040
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36226630-6F63694E-E790-4FC5-A0A7-215401847040
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a69e25989e2ef46c98852c7a4d32876f7be3e7cf
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.